Aehr Test Systems (AEHR)
(Delayed Data from NSDQ)
$10.36 USD
-0.46 (-4.25%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $10.37 +0.01 (0.10%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth C Momentum F VGM
Balance Sheet
Fiscal Year End for Aehr Test Systems falls in the month of May.
All items in Millions except Per Share data.
5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 48 | 31 | 5 | 5 | 5 |
Receivables | 17 | 13 | 5 | 4 | 5 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 24 | 15 | 9 | 8 | 9 |
Other Current Assets | 1 | 1 | 1 | 1 | 1 |
Total Current Assets | 89 | 60 | 19 | 18 | 20 |
Net Property & Equipment | 3 | 1 | 1 | 1 | 1 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 98 | 62 | 22 | 21 | 21 |
Liabilities & Shareholders Equity | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 1 | 0 | 0 |
Accounts Payable | 9 | 4 | 3 | 1 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 2 | 1 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 4 | 4 | 2 | 1 | 2 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 3 | 2 | 0 | 0 | 2 |
Total Current Liabilities | 16 | 11 | 9 | 4 | 6 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 1 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 23 | 11 | 10 | 7 | 6 |
Shareholders Equity | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 128 | 118 | 88 | 86 | 85 |
Retained Earnings | -52 | -67 | -76 | -74 | -71 |
Other Equity | 0 | 0 | 0 | 2 | 2 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 76 | 51 | 11 | 14 | 15 |
Total Liabilities & Shareholder's Equity | 98 | 62 | 22 | 21 | 21 |
Total Common Equity | 76 | 51 | 11 | 14 | 15 |
Shares Outstanding | 28.30 | 26.90 | 23.60 | 23.00 | 22.50 |
Book Value Per Share | 2.67 | 1.90 | 0.49 | 0.61 | 0.69 |
Fiscal Year End for Aehr Test Systems falls in the month of May.
All items in Millions except Per Share data.
2/29/2024 | 11/30/2023 | 8/31/2023 | 5/31/2023 | 2/28/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 48 | 51 | 51 | 48 | 43 |
Receivables | 5 | 5 | 13 | 17 | 11 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 38 | 34 | 32 | 24 | 22 |
Other Current Assets | 1 | 3 | 1 | 1 | 1 |
Total Current Assets | 92 | 92 | 96 | 89 | 77 |
Net Property & Equipment | 3 | 3 | 3 | 3 | 1 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 102 | 101 | 105 | 98 | 84 |
Liabilities & Shareholders Equity | 2/29/2024 | 11/30/2023 | 8/31/2023 | 5/31/2023 | 2/28/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 5 | 4 | 8 | 9 | 5 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 3 | 3 | 5 | 4 | 3 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 6 | 3 | 1 |
Total Current Liabilities | 9 | 8 | 19 | 16 | 9 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 15 | 14 | 25 | 23 | 16 |
Shareholders Equity | 2/29/2024 | 11/30/2023 | 8/31/2023 | 5/31/2023 | 2/28/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 129 | 129 | 128 | 128 | 127 |
Retained Earnings | -43 | -42 | -48 | -52 | -58 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 87 | 87 | 80 | 76 | 69 |
Total Liabilities & Shareholder's Equity | 102 | 101 | 105 | 98 | 84 |
Total Common Equity | 87 | 87 | 80 | 76 | 69 |
Shares Outstanding | 28.80 | 28.80 | 28.70 | 28.30 | 27.70 |
Book Value Per Share | 3.00 | 3.03 | 2.79 | 2.67 | 2.48 |